Market Introduction
The Middle East and Africa joint pain injection market is a highly fragmented market with the presence of considerable regional and local players providing numerous solutions for companies investing in the market arena. Hyaluronic acid injections offered by companies are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function. Corticosteroids are also used to treat sports-related injuries. Sports injuries are caused due to direct impact, or the application of force that is larger than the body part can withstand. The most common sport injuries are sprains, strains, joint injuries, and bruises. People involved in football, bicycling, basketball, playground, and soccer activities contributed to the highest number of emergency department (ED) visits in that year. It also states sport injuries affect over thousands of youth population engaged in various sports.
Several Middle Eastern and African countries witnessed an unprecedented rise in the number of COVID-19 cases which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market during the early months of 2020. Shortage of hospital supplies also accelerate the criticality of the condition. During the pandemic, the focus of healthcare professionals was only limited to the covid management, which substantially hampered the number of elective surgeries in the region. Moreover, implementation of social distancing policies resulted into limited patients visits to orthopedic centers, which drastically impacted the demand and adoption of joint pain injections in Middle East and Africa. Apart from this, a huge population already face a growing burden of non-communicable diseases, making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region.
Market Overview and Dynamics
The joint pain injection market in Middle East and Africa is expected to grow from US$ 49.82 million in 2021 to US$ 75.57 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2021 to 2028. Countries in Middle East and Africa are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Flourishing domestic pharmaceutical market and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Saudi Arabia is among the largest economies in the Middle East region. Country's economy is most flourishing, which is supported by the diversified initiatives and increasing population. The growing demand for generic production and increasing international players' expansions into the country have provided substantial growth for the pharmaceutical industry. Additionally, the country-based companies have initiated importing raw materials for producing a generic version of the foreign-made branded medicines. The aging population in the UAE is likely to demand joint replacement procedures in the UAE. In 2017, Dubai Health Authority indicated the country's older population - people aged 65 and over - would increase from 6% to 29% by 2050. Furthermore, rising prevalence of osteoarthritis is likely to demand for joint replacement therapies in the UAE. Osteoarthritis is one of the prominent causes of disability in the UAE with around 50% of the old age population (people above 65 years and above), suffering from the chronic conditions. Some 25% of people over the age of 60 years have significant pain and disability caused by osteoarthritis. These factors are expected to have positive impact on the growth of the UAE joint pain injection market during the forecast period.
Key Market Segments
Based on drugs, the hyaluronic acid segment accounted for the largest share of the Middle East and Africa joint pain injection market in 2020. Based on joint type, the knee segment accounted for the largest share of the Middle East and Africa joint pain injection market in 2020. Based on distribution channel, the hospitals pharmacies segment accounted for the largest share of the Middle East and Africa joint pain injection market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Middle East and Africa joint pain injection market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report include Bioventus Inc.; Fidia Pharma USA Inc.; Ferring B.V.; Sanofi; Anika Therapeutics, Inc; and Teva Pharmaceutical Industries Ltd.
Reasons to buy report
Middle East and Africa Joint Pain Injection Market Segmentation
Middle East and Africa Joint Pain Injection Market -By Drugs
Middle East and Africa Joint Pain Injection Market -By Joint Type
Middle East and Africa Joint Pain Injection Market -By Distribution Channel
Middle East and Africa Joint Pain Injection Market – By Country
Middle East and Africa Joint Pain Injection Market – Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 49.82 Million |
| Market Size by 2028 | US$ 75.57 Million |
| CAGR (2021 - 2028) | 6.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Drugs
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Joint Pain Injection Market is valued at US$ 49.82 Million in 2021, it is projected to reach US$ 75.57 Million by 2028.
As per our report Middle East and Africa Joint Pain Injection Market, the market size is valued at US$ 49.82 Million in 2021, projecting it to reach US$ 75.57 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The Middle East and Africa Joint Pain Injection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Joint Pain Injection Market report:
The Middle East and Africa Joint Pain Injection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Joint Pain Injection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Joint Pain Injection Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Joint Pain Injection Market
